TRABAJO ORIGINAL
Non acid gastroesophageal
reflux episodes decrease with age as determined by
multichannel intraluminal impedance-ph monitoring in
symptomatic children.
Disminucion con la edad de los episodios de reflujo
gastroesofagico no acido determinados por impedancia
intraluminal multicanal y phmetria en niños sintomaticos
Marina Orsi,
Judith Cohen-Sabban, Carlos Grandi, María Gabriela Donato,
Carlos Lifschitz, Daniel D’Agostino.
Revista Facultad de Ciencias
Medicas 2011; 68(1): 8-13
Hospital Italiano, Servicio de
Gastroenterología y Hepatología Infantil, Gascón 450,
(C1181ACH), Buenos Aires, Argentina.
Marina.Orsi@hospitalitaliano.org.ar
Introduction
Many young infants experience gastroesophageal reflux (GER)
which progressively improves until it disappears the latest
at one and one half years of age (1,2) The multichannel
intraluminal impedance (MII) records acid and non acid
reflux events (3,4). The system records changes in
resistance (in Ohms) as a result of alternating electrical
current that occurs whenever a bolus passes by a pair of
metallic electrodes mounted on a catheter. Combined with pH
(multichannel intraluminal impedance and pH; MII-pH) it
permits detection of both acid and non-acid gastroesophageal
reflux. MII detects bolus refluxate independent of the pH
composition of the refluxate, whereas the pH sensor cannot
differentiate reflux from a swallow (5,6). The aim of this
study was to determine whether changes related to age in GER
in infants and children presenting with either
gastrointestinal or pulmonary symptoms are due to acid, non
acid reflux or both, as determined by pH-MII.
Methods
The records of 243 infants and children referred by
pneumonologists, otorrhinolaringologists and pediatricians
to the Pediatric Gastroenterology Unit of the Hospital
Italiano in Buenos Aires, Argentina between January 2005 and
December 2006 for the evaluation of their GER symptoms were
reviewed. Patients with cardiac disease, congenital
anomalies, feeding disorders, mental retardation and
cerebral palsy were excluded. Patients receiving gastric
acid suppressing drugs had their medication discontinued 2
wks prior to the study. GER symptoms were divided into: 1)
Digestive, which were subclassified as being (a) epigastric
(pain, upper abdominal pain, and/or heartburn), (b) emesis,
(c) irritability, crying, d) non mechanical feeding
difficulties and, 2) Respiratory: (a) low respiratory
symptoms (recurrent pneumonia, wheezing, obstructive
bronchitis and bronchospasm), (b) high respiratory symptoms
(recurrent cough, hoarseness and throat clearing, (c)
suffocation (choking, acute life threatening episode, and
apneas). Patients with digestive symptoms were referred to
us because of persistence or recurrence of symptoms despite
adequate initial management by their primary physicians.
These patients were considered to have GER if the clinical
history was supportive of that diagnosis. All had an upper
gastrointestinal radiological study to rule out a duodenal
anatomical malformation or malrotation. Patients with
respiratory symptoms were referred to us because of failure
to respond to management of their pulmonary symptoms as
implemented by their primary physicians or pediatric
pulmonologists. Patients presenting with more than one
symptom were classified according to the main symptom or
primary reason for consultation.
Procedure
Patients were admitted to the hospital for a 24 hr
continuous study evaluating the preprandial, postprandial
and sleep periods using pH-MII testing. The pH sensor is
located within the distal channel. The length of the
catheter was chosen according to the patient’s age. Correct
catheter placement was confirmed by a chest radiograph.
Parents and patients were instructed to maintain as normal a
daily routine and diet as possible. Before the initiation of
the study, caretakers were asked to identify three symptoms
of concern for their child. Three buttons in the recording
machine were labeled with these symptoms and caretakers were
asked to press the appropriate one whenever their child
presented that symptom during the study. pH-MII tracings
were evaluated using BioVIEW analysis software (Sandhill
Scientific, Inc. Highlands Ranch, CO, USA), and each study
was manually reviewed by one of the investigators.
pH-MII analysis
Using the pH-MII technique, we identified liquid refluxate
and whether reflux was acid or non acid. An impedance
detected reflux event was defined as a retrograde bolus
movement across at least two channels that caused the
impedance to drop at least 50% from baseline (7). To label
the impedance detected refluxate as acid, the pH had to fall
below 4.0 any time the bolus was physically present in the
distal channel. Symptoms such as choking while not being fed,
cough, intense crying and vomiting were considered related
to a reflux event if it occurred within a 5 min window (5
min before a reflux event, the time that was accepted at the
time when these studies were performed, or immediately after)
(8,9). If a symptom recurred within 1 minute, this symptom
record was considered a duplicate of the preceding symptom
and was removed from the analysis. To evaluate the detection
of a reflux event in relation to the time from the last meal,
reflux records that occurred before the first meal were not
included in the analysis. The following parameters were
considered as normal when calculating pH score (percent of
the time that esophageal pH was below 4): number of episodes
with pH below 4, episodes longer than 5 min: <5.8, total
reflux time <5.1, most prolonged episode: <22.4, total
number of reflux episodes: <27.0 (10,11). The bolus exposure
time value used was that reported by the Sandhill autoscan.
Data analysis
Patients were grouped according to their primary presenting
symptoms into a digestive (regurgitation, vomiting,
epigastric pain, heartburn) or a respiratory (recurrent
cough, laryngitis, pneumonia, bronchospasm, asthma) group.
Patients were divided in two age groups according the median
age.
Statistical Analysis
The normality of data was assessed using the
Kolmogorov-Smirnov and Lillefors tests. For the purpose of
descriptive analysis, mean or median (first and third
quartiles) were applied in the case of normal or non-parametric
distributions. The Mann-Whitney U and Differences at 0.05
level were considered significant. For all statistical
analyses, Statistica (Version 6.0, Statsoft, Tulsa, OK) was
used.
Result
Two hundred and forty three infants and children were
included, (144 males; mean [+ SD] age was 3.9 + 4.5 yrs [range
0.04 – 18.0 yrs]). Two patients had uninterpretable data in
both tests and were excluded from analysis, therefore data
from 241 are presented. In the few cases where recordings
experienced technical problems, those studies were also
excluded from the analyses. The sensitivity (SSI) and
probability index (SAP) were not analyzed. Actual number of
studies analyzed for each parameter is listed in the Tables.
Age
Median and inter quartile range for the whole population was
1.91 [0.41 -7.0 yrs. and this was adopted as a cut-off value.
pH probe
Median (inter quartile range) of the total number of GER
episodes among 241 patients was 117 (16.4 -166) with a range
from 0 to 243. No significant differences were found between
the pH scores of patients with digestive symptoms (median,
1st - 3rd quartile) (7.15, 3.3 – 18.1) and those with
respiratory symptoms (5.95, 2.6 – 14.8), (p = 0.096) or
between those with high (6.2, 2.6 – 14.6) or low respiratory
symptoms (5.8, 2.2 – 12.8), (p = 0.997) (Table 1). Also, no
significant differences were found in the total number of
GER episodes of those with digestive symptoms (124.5, 26 –
173) compared to those with high or low respiratory symptoms
(117, 15.2 – 154), (p = 0.113).
However, when data were analyzed according to age, a
significantly higher total number of GER episodes were
observed in children under the age of 1.91 yr (22.8 mos)
compared to those who were older (median 159 vs. 110.5, p
=0.002). Fifty one percent of the patients (n=124) were 22.8
mos of age or younger. However, there was no statistically
significant difference in the pH score between the younger
and older children.
MII
Bolus clearance was significantly faster in the younger
group (median 14 seconds, range 11-16) vs. 16 seconds
(14-20) (p = 0.001) (Mann-Whitney U Test). The percentage of
time acid exposure of the esophagus failed to reach
significant difference between the younger and older
children (median 0.8 and 1, respectively; p = 0.057).
Finally, there was no significant difference between the
younger and older age groups with respect to the median
number of GER episodes that reached channels 1 and 2: 65.4
vs. 118 (p = 0.306).
Median (inter quartile range) total number of GER episodes
detected by MII among 243 patients was 40 (26 -58). Of these,
20.5 (10 -34) were acid and 16 (9 -29) non acid. Of these, a
mean of 29.7(+ 67.2) (IC 95% 21 – 38) were acid and 20.6 (+
17) (IC 95% 18.4 – 22.7) non acid. As seen with the pH probe,
children older than 1.91 yr (22.8 mos) had a significantly
lower number of GER episodes than those who were younger for
both clinical presentations, digestive and high and low
respiratory symptoms (Table 1). When GER episodes were
separated into acid and non acid, significant differences
related to the 22.8 mos cut-off age were seen in the total
number of non acid GER episodes for children with either
digestive, total respiratory or high/low respiratory
symptoms but no significant changes for acid episodes (Table
2).
Comparison of pH probe and MII
Comparing the median total number of GER episodes detected
by the two techniques, the pH probe consistently showed a
higher number of GER episodes for all patients regardless of
their presenting symptoms or age (Table 1). The only
concordance between pH probe and MII among the factors
analyzed was the finding of the difference in the number of
GER episodes above or below the age of 22.8 mos.
Discussions
Recently published guidelines for pediatric gastroesophageal
reflux indicate that combined pH and MII monitoring is
superior to pH monitoring alone for evaluation of the
temporal relation between symptoms and GER (10). In our
study we used a standard protocol for the interpretation of
pH recordings to measure acid reflux (11,12). The MII test
detects the bolus of refluxate and is therefore independent
of pH, providing a more accurate determination of reflux of
any sort into the esophagus (13).
We were able to identify a difference in the median number
of reflux episodes among symptomatic patients according to
their age. In that regard, we found that for several of the
parameters measured, 22.8 mos was the age after which the
median number of events recorded decreased significantly. As
we stated, that age was the median of the group studied and
we used that arbitrarily, as it is close to 18 mos, when
children are found, at least clinically, to outgrow their
reflux symptoms (1,2). A more recent study indicated that
88% of 210 infants with GER who had completed a 24 mos
follow-up period had improved at the age of 12 mos and only1
patient later turned out to have GER disease (14). Although
we do not present follow up studies of our study patients,
it would seem that, as a group, older patients who are
symptomatic have lower number of GER episodes than younger
ones
We confirmed several findings of previous studies. In this
large number of patients studied, we have also documented a
greater number of GER episodes of pH only compared to those
of bolus GER (5,15). Studies in adults and children have
recognized the significant role of non acid reflux,
previously undetectable when the pH probe technique was used
by itself (16). Non acid reflux has been identified as being
more prevalent than acid reflux. Our study not only
corroborated that predominance but allowed us to identify a
decrease in the median number of these episodes among
symptomatic children older than 22.8 mos. Such age
differences were significant for total number of GER
episodes, for patients with predominantly digestive symptoms
and for those with predominantly respiratory symptoms, both
for total number of episodes and for those who presented
high and low respiratory symptoms. Interestingly, there was
no significant decrease with age on acid reflux. Our study
did not address, however, the fact that greater day to day
variation has been found with respect to non acid than to
acid reflux (17). Our data indicate that the number of non
acid reflux episodes is more dependent on age than acid
episodes, and that supports the idea that MII may be useful
for the study of the physiopathology of GER. Although
statistically we also found a significantly shorter
clearance time among the younger group, it may be that
clinically that difference is not relevant.
One of the findings in this study is that there was no
significant decrease of acid GER with age. This is in
contrast with the current gold standard, the pH-metry that
has a higher cut-off value in infants than in children, as
defined by Vandenplas (18). There are several explanations
to this discrepancy. One explanation could be that the pH
probe is unable to differentiate between variations related
to acidic feeding (yoghurt-fruit juices-soda beverages) so
common in infant feedings from true pH drops related to acid
reflux.. Additionally, being ours a retrospective study,
there could have been a bias to studying children who were
very symptomatic and thus a decrease in pH scores was not
observed.
A limitation of this study is that we did not take into
consideration mixed reflux episodes, which are a combination
of air and liquid refluxate that have a significant role in
GER, nor the so called acid vapor gaseous refluxes. The
reason for this is that at the time we performed the studies,
investigators were not aware of the relevance of these
episodes.
Guidelines by the North American and European Societies for
Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN/ESPGHAN,
respectively) recommend the use of MII to study patients
suspected of having GER who are on acid suppressing
medication while the pH probe should be used in those not
receiving those medications (10). Recent data indicates that
MII-pH doubles the probability of documenting an association
between symptoms and reflux compared with pH monitoring
alone (6,18). In addition, in young infants, symptoms are
more frequently associated with weakly AR than with AR a
parameter that we did not record in our study (19).
In conclusion, after the median age of 22.8 mo. we observed
a decrease of non acid reflux. This finding may have an
impact on the choice of therapeutic modalities in children
versus infants as well as better understanding their
response to available medications.
References
1. Nelson, S P, Chen, E, Syniar, G M, et al. Prevalence of
symptoms of gastroesophageal reflux during infancy: a
paediatric practice-based survey. Arch Pediatr Adolesc Med
1997;151:569 –572
PubMed
2. Martin, J, Pratt, N, Declan Kennedy, J, et al. Natural
History and Familial Relationships of Infant Spilling to 9
Years of Age. Pediatrics 2002;109:1061-1067
PubMed
3. Skopnik, H, Silny, J, Heiber, O, et al. Gastroesophageal
reflux in infants: evaluation of a new intraluminal
impedance technique. J Pediatr Gastroenterol Nutr 1996;
23:591–598
PubMed
4. Wenzl T. Invited review: investigating reflux with the
intraluminal impedance technique. J Pediatr Gastroenterol
Nutr 2002; 34:261–268
5. Rosen, R, Lord, C, Nurko, S. The sensitivity of
multichannel intraluminal impedance and the pH probe in the
evaluation of gastroesophageal reflux in children. Clin
Gastroenterol Hepatol 2006; 4:167-172
PubMed
6. Francavilla, R, Magistà, A M, Bucci, N, et al. Comparison
of esophageal pH and multichannel intraluminal impedance
testing in pediatric patients with suspected
gastroesophageal reflux. J Pediatr Gastroenterol Nutr.
2010;50:154-60.
PubMed
7. Shay, S, Tutuian, R, Sifrim, D, et al. Twenty-four hour
ambulatory simultaneous impedance and pH monitoring: a
multicenter report of normal values from 60 healthy
volunteers. Am J Gastroenterol 2004; 99:1037–1043
PubMed
8. Wiener, G J, Richter, J E, Copper, J B, et al. The
symptom index: a clinically important parameter of
ambulatory 24-hour esophageal pH monitoring. Am J
Gastroenterol 1988;83:358–361
PubMed
9. Vela, M F, Camacho-Lobato, L, Srinivasan, R, et al.
Simultaneous intraesophageal impedance and pH measurement of
acid and nonacid gastroesophageal reflux: effect of
omeprazole. Gastroenterology 2001;120:1599–1608
PubMed
10. Rosen, R, Nurko, S. The importance of multichannel
intraluminal impedance in the evaluation of children with
persistent respiratory symptoms. Am J Gastroenterol
2004;99:2452–2458
PubMed
Full Text
11. Vandenplas, Y, Rudolph, C D, Di Lorenzo, C, et al.
Pediatric Gastroesophageal Reflux Clinical Practice
Guidelines: Joint Recommendations of the North American
Society for Pediatric Gastroenterology, Hepatology, and
Nutrition (NASPGHAN) and the European Society for Pediatric
Gastroenterology, Hepatology, and Nutrition (ESPGHAN) J
Pediatr Gastroenterol Nutr 2009;49:498-547
Full text
12. Sondheimer, J M. Continuous monitoring of distal
esophageal pH: a diagnostic test for gastroesophageal reflux
in infants. J Pediatr 1980;96:804–807
PubMed
13. Vandenplas, Y, Belli, D, Boige, N, et al. A standardized
protocol for the methodology of esophageal pH monitoring and
interpretation of the data for the diagnosis of
gastroesophageal reflux. Statement of the European Society
of Pediatric Gastroenterology and Nutrition (ESPGAN). J
Pediatr Gastroenterol Nutr 1992;14:467–471
14. Campanozzi, A, Boccia, G, Pensabene, J, , et al.
Prevalence and Natural History of Gastroesophageal Reflux:
Pediatric Prospective Survey. Pediatrics 2009;123:779–783
Full text
15. Woodley, F W, Mousa, H. Acid gastroesophageal reflux
reports in infants: a comparison of esophageal pH monitoring
and multichannel intraluminal impedance measurements.Dig Dis
Sci 2006;51:1910-1916
PubMed
16. Condino, A A, Sondheimer, J, Pan, Z, et al. Evaluation
of Infantile Acid and Nonacid Gastroesophageal Reflux Using
Combined pH Monitoring and Impedance Measurement. J Pediatr
Gastroenterol Nutr 2006;42:16–21
PubMed
17. Dalby, K, Nielsen, R G, Markoew, S, et al.
Reproducibility of 24-hour combined multiple intraluminal
impedance (MII) and pH measurements in infants and children.
Evaluation of a diagnostic procedure for gastroesophageal
reflux disease. Dig Dis Sc 2007;52:2159-2165
PubMed
18. Vandenplas, Y, Ashkenazi, A, Bell,i D, et al. A
proposition for the diagnosis and treatment of gastro-oesophageal
reflux disease in children: a report from a working group on
gastro-oesophageal reflux disease. Working Group of the
European Society of Paediatric Gastroenterology and
Nutrition (ESPGAN). Eur J Pediatr. 1993;152:704-11
PubMed
19. Salvatore, S, Arrigo, S, Luini, C, et al. Esophageal
Impedance in Children: Symptom-Based Results. J Pediatr.
2010;157:949-954.e1-2
PubMed

|